Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Poll

Poll: Initial Treatment for RA
Poll
Poll: Initial Treatment for RA
06/22/2020
The European League Against Rheumatism (EULAR) recently updated its recommendations for the management of rheumatoid arthritis (RA) with disease-modifying anti-rheumatic drugs (DMARDS), developing 12 recommendations...
The European League Against Rheumatism (EULAR) recently updated its recommendations for the management of rheumatoid arthritis (RA) with disease-modifying anti-rheumatic drugs (DMARDS), developing 12 recommendations...
The...
06/22/2020
Rheumatology & Arthritis
Poll: Clinical Assessment Risk Tools in Osteoporosis
Poll
Poll: Clinical Assessment Risk Tools in Osteoporosis
05/19/2020
Which clinical assessment risk tool do you use to assess osteoporosis risk?Simple Calculated Osteoporosis Risk EstimationOsteoporosis Risk Assessment InstrumentOsteoporosis Index of RiskFracture Risk Assessment...
Which clinical assessment risk tool do you use to assess osteoporosis risk?Simple Calculated Osteoporosis Risk EstimationOsteoporosis Risk Assessment InstrumentOsteoporosis Index of RiskFracture Risk Assessment...
Which...
05/19/2020
Rheumatology & Arthritis
Poll: Immunoautonomics for Predicting Treatment Outcomes
Poll
Poll: Immunoautonomics for Predicting Treatment Outcomes
04/16/2020
In your opinion, do you feel that immunoautonomics can accurately predict tumor necrosis factor inhibitor treatment outcomes in patients with rheumatoid arthritis?YesNoUnsure
In your opinion, do you feel that immunoautonomics can accurately predict tumor necrosis factor inhibitor treatment outcomes in patients with rheumatoid arthritis?YesNoUnsure
In...
04/16/2020
Rheumatology & Arthritis

Advertisement

Poll: First-Line Therapy for GIOP
Poll
Poll: First-Line Therapy for GIOP
04/06/2020
Because glucocorticoid-induced osteoporosis (GIOP) is becoming a more common issue in rheumatology practice, it is important for rheumatologists to understand anabolic and antiresorptive agents for treating GIOP....
Because glucocorticoid-induced osteoporosis (GIOP) is becoming a more common issue in rheumatology practice, it is important for rheumatologists to understand anabolic and antiresorptive agents for treating GIOP....
...
04/06/2020
Rheumatology & Arthritis
Poll: Complications of a Compression Fracture
Poll
Poll: Complications of a Compression Fracture
03/16/2020
Which complications of a compression fracture do you manage most often among your patients?Thrombosis in upper or lower extremitiesFractures that have not healed after treatmentKyphosisChronic painOther ...
Which complications of a compression fracture do you manage most often among your patients?Thrombosis in upper or lower extremitiesFractures that have not healed after treatmentKyphosisChronic painOther ...
Which...
03/16/2020
Rheumatology & Arthritis
Poll: Classifying IgG4‐Related Disease
Poll
Poll: Classifying IgG4‐Related Disease
03/05/2020
A multispecialty group has developed and validated the first international set of classification criteria for IgG4‐related disease (IgG4‐RD). Do you think the classification criteria can help facilitate the...
A multispecialty group has developed and validated the first international set of classification criteria for IgG4‐related disease (IgG4‐RD). Do you think the classification criteria can help facilitate the...
A...
03/05/2020
Rheumatology & Arthritis

Advertisement

Poll: Barriers to Vaccination Strategies in Immune-Mediated Inflammatory Diseases
Poll
Poll: Barriers to Vaccination Strategies in Immune-Mediated Inflammatory Diseases
02/13/2020
What challenges do you experience when creating a vaccination strategy for your patients with immune-mediated inflammatory diseases (IMIDs)?I do not have enough time to properly educate my patients on vaccinations.I...
What challenges do you experience when creating a vaccination strategy for your patients with immune-mediated inflammatory diseases (IMIDs)?I do not have enough time to properly educate my patients on vaccinations.I...
What...
02/13/2020
Rheumatology & Arthritis
Poll: Cervical Screening in Lupus
Poll
Poll: Cervical Screening in Lupus
02/12/2020
Do you recommend cervical cancer screening to all of your female patients with lupus?YesNo
Do you recommend cervical cancer screening to all of your female patients with lupus?YesNo
Do...
02/12/2020
Rheumatology & Arthritis
Poll: Patient-Reported Outcome Measures in PsA
Poll
Poll: Patient-Reported Outcome Measures in PsA
02/11/2020
Which patient-reported outcome (PRO) measure do you most often use to assess function among patients with psoriatic arthritis (PsA)?HAQ‐DIPCS-12PsAID‐FCNone of the aboveOther
Which patient-reported outcome (PRO) measure do you most often use to assess function among patients with psoriatic arthritis (PsA)?HAQ‐DIPCS-12PsAID‐FCNone of the aboveOther
...
02/11/2020
Rheumatology & Arthritis

Advertisement

Poll: Multidisciplinary Approach to SLE During Pregnancy
Poll
Poll: Multidisciplinary Approach to SLE During Pregnancy
02/01/2020
Which specialist do you often collaborate with when managing systemic lupus erythematosus (SLE) in a pregnant patient? Maternal-fetal medicine specialistNephrologistHematologistPulmonologistAll of the...
Which specialist do you often collaborate with when managing systemic lupus erythematosus (SLE) in a pregnant patient? Maternal-fetal medicine specialistNephrologistHematologistPulmonologistAll of the...
...
02/01/2020
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay in the Know

Rheumatology & Arthritis Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
Interleukin Inhibitors Effective Among TNFi-Exposed Patients With PsA
05/16/2022
Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.
Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.
Investigators set out to...
05/16/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use